Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute of Human Genetics, |
RCV000016000 | SCV001950086 | likely pathogenic | Synpolydactyly type 1 | 2021-07-21 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003450643 | SCV004183505 | pathogenic | Brachydactyly type E1 | 2023-10-07 | criteria provided, single submitter | clinical testing | |
Genomic Medicine Center of Excellence, |
RCV000016000 | SCV004806003 | pathogenic | Synpolydactyly type 1 | 2024-03-25 | criteria provided, single submitter | clinical testing | |
Gene |
RCV005054139 | SCV005687911 | pathogenic | not provided | 2024-07-30 | criteria provided, single submitter | clinical testing | Published functional studies demonstrate a damaging effect: p.(R306W) resulted in altered binding specificity (PMID: 27013732); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Also known as R31W; This variant is associated with the following publications: (PMID: 12414828, 27013732) |
OMIM | RCV000016000 | SCV000036267 | pathogenic | Synpolydactyly type 1 | 2002-11-01 | no assertion criteria provided | literature only |